AGP Picks
View all

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on July 14, 2026

Kentico Reports Strong Year-Over-Year Growth Driven by Customer Adoption, Partner Success, and AI Innovation
Naqi Logix Announces $15 Million Reg A+ Offering to Advance Its AI-Neurotechnology Platform
Spire Healthcare announced as exclusive Team GB Official Healthcare Services Partner
Visory Health gana un Digital Health Award por segundo año consecutivo
Burial Insurance Market Size & Growth: USD 326.49 Bn in 2026, USD 463.13 Bn by 2033 at 6.0% CAGR | Transamerica
Adrienne Wilkerson of Beacon Media + Marketing to Speak at Recovery.com Marketing Summit in Madison, WI
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026
DBV Technologies présente ses résultats financiers du premier semestre 2026 et fait le point sur ses activités le 16 julliet 2026
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy
Tokyo-Based 'Zenkyu Matcha' Expands in London with Exclusive Workshop at British Sustainable Fashion Label 'Story mfg.'
ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
AVITA Medical to Announce Second Quarter 2026 Financial Results
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.